Definition | |
1 | Does the definition of remission require measurement of inflammation? |
2 | How do asthma control and severity relate to asthma remission? |
Treatment-induced remission | |
3 | Is treatment-induced remission possible? |
4 | How does treatment-induced remission compare with spontaneous asthma remission, based on prevalence, predictors and risk of relapse? |
5 | Is it possible to increase the proportion of people achieving remission with treatment? |
6 | Is it possible to prolong the remission period with treatment? |
7 | What are the rates of remission with MART and step therapy? |
8 | Does prolonging asthma treatment after control is achieved increase the chance of asthma remission? |
Trajectory of remission | |
9 | How long should the treatment be continued to achieve remission? When to move from one stage to another? |
Pathophysiology | |
10 | What are the molecular events leading to airway remodelling? |
11 | Can airway remodelling be treated? |
12 | Does treating airway remodelling induce remission? |
Relapse | |
13 | How does ongoing airway inflammation and remodelling affect relapse? |
14 | How can inflammation/remodelling be effectively treated to prevent relapse in those who are in clinical remission? |
Biologics and asthma remission | |
15 | What is the prevalence of remission after biologics therapy for asthma? |
16 | Are biologics more effective than inhaled preventers at achieving asthma remission? |
17 | Does the early introduction of biologics modify the trajectory of asthma and halt the disease progression? |
18 | Does continuing the treatment with biologics prolong remission and prevent relapse? |
19 | Is it possible to stop all asthma treatments except biologics in a patient who has achieved remission with biological therapies? |
Macrolide therapy | |
20 | What is the prevalence of remission after macrolide therapy for asthma? |
Treatable traits | |
21 | Does targeting treatable traits increase the chance of asthma remission? |
MART: maintenance and reliever therapy.